Zulueta Aída, Hermida Lisset, Lazo Laura, Valdés Iris, Rodríguez Rayner, López Carlos, Silva Ricardo, Rosario Delfina, Martín Jorge, Guzmán María G, Guillén Gerardo
División de Vacunas, Centro de Ingeniería Genética y Biotecnologi;a, Habana, Cuba.
Biochem Biophys Res Commun. 2003 Aug 29;308(3):619-26. doi: 10.1016/s0006-291x(03)01411-6.
To characterize the effect of the envelope fragment fusion site in the P64k protein from Neisseria meningitidis several chimeric constructs were obtained. One variant consisted in the insertion of the E fragment from each Dengue serotype within the lipoil binding domain of the P64k, whereas the other was based on the fusion of the envelope fragment at the C-terminus of the same meningoccocal protein. The results of the expression study revealed the majoritary levels with the C-terminus fusion variants of each serotype. In contrast, the highest proportion of soluble protein was reached with the insertion variants independently of the viral serotype. On the other hand, a significant level of degradation was detected for the semipurified forms of the insertion variants being remarkable in the Dengue 2 construct. Finally, the recognition by Dengue murine antibodies was similar independently of the fusion site. Regarding these results, we can affirm the suitability of the C-terminus fusion variants for further vaccine development as well as for a diagnostic system.
为了表征来自脑膜炎奈瑟菌的P64k蛋白中包膜片段融合位点的作用,获得了几种嵌合构建体。一种变体是在P64k的脂油结合结构域内插入来自每种登革热血清型的E片段,而另一种则基于包膜片段与同一脑膜炎球菌蛋白C末端的融合。表达研究结果显示,每种血清型的C末端融合变体表达水平较高。相比之下,插入变体的可溶性蛋白比例最高,与病毒血清型无关。另一方面,检测到插入变体的半纯化形式有显著水平的降解,在登革热2构建体中尤为明显。最后,登革热鼠源抗体的识别情况与融合位点无关。基于这些结果,我们可以肯定C末端融合变体适用于进一步的疫苗开发以及诊断系统。